Home
About
Corporate Mission
Leadership
Advisors
Products
Ordering Information
Intellectual Property
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2021
2020
2019
2018
2017
2016
2015
2014
2013
02/5/18
Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5™ in a Topical Application
01/2/18
Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January 8th, 2018
12/18/17
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
11/28/17
Arch Therapeutics to Provide Corporate Update at the 10th Annual LD Micro Main Event In Los Angeles December 5-7, 2017
09/20/17
Arch Therapeutics to Provide Corporate Updates at Upcoming Industry and Investment Conferences
09/12/17
Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5™ for Subchronic Systemic Toxicity
09/6/17
Arch Therapeutics to Provide Corporate Update at the 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017
07/25/17
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
06/6/17
Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
05/22/17
Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>
Show All